Annexon’s ANX007 Misses GA Endpoint, But May Have Visual Acuity Path Forward

 
• By Alaric DeArment
  
Annexon announced results of the Phase II ARCHER study of ANX007 in geographic atrophy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Sensory

More from Therapeutic Category